Rymedi develops a platform for healthcare testing, reporting and patient data management.
Rymedi's platform connects medical professionals and customers, supports test collection and reporting, and automates state reporting. Its blockchain-based system is designed to manage health data securely and supports integrations and adaptable workflows. Founded in 2017, the company is based in Greenville, US, and was at the Series A stage. In October 2023, it raised USD 9 million co-led by RW3 Ventures and White Star Capital, with participation from Avalanche VC and Blockchange Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in